Hong Kong
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
40.51%
|
Dec. 31, 2023 | USD 0.31 | 0.39% |
|
Hong Kong |
|
2 |
29.96%
|
Dec. 31, 2023 | USD 0.91 | -0.72% |
|
Hong Kong |
|
3 |
29.29%
|
Dec. 31, 2023 | USD 0.47 | -0.57% |
|
Hong Kong |
|
4 |
28.32%
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
5 |
24.80%
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
6 |
20.40%
|
Dec. 31, 2023 | USD 0.41 | 1.55% |
|
Hong Kong |
|
7 |
20.12%
|
March 31, 2024 | USD 0.22 | -1.75% |
|
Hong Kong |
|
8 |
19.66%
|
Dec. 31, 2023 | USD 1.42 | 0.70% |
|
Hong Kong |
|
9 |
18.19%
|
March 31, 2024 | USD 0.13 | 1.98% |
|
Hong Kong |
|
10 |
17.61%
|
Dec. 31, 2023 | USD 0.18 | -0.02% |
|
Hong Kong |
|
11 |
12.74%
|
Dec. 31, 2023 | USD 0.53 | 5.07% |
|
Hong Kong |
|
12 |
12.72%
|
Dec. 31, 2023 | USD 0.83 | 3.07% |
|
Hong Kong |
|
13 |
12.03%
|
Dec. 31, 2023 | USD 3.02 | 2.59% |
|
Hong Kong |
|
14 |
8.90%
|
Dec. 31, 2023 | USD 0.37 | 1.03% |
|
Hong Kong |
|
15 |
7.09%
|
Dec. 31, 2023 | USD 0.26 | 1.45% |
|
Hong Kong |
|
16 |
4.16%
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
17 |
3.27%
|
March 31, 2024 | USD 0.43 | 2.74% |
|
Hong Kong |
|
18 |
1.59%
|
Dec. 31, 2023 | USD 0.16 | -0.02% |
|
Hong Kong |
|
19 |
1.47%
|
Dec. 31, 2023 | USD 0.21 | 10.11% |
|
Hong Kong |
|
20 |
1.43%
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
21 |
-1.45%
|
Dec. 31, 2023 | USD 0.10 | 0.02% |
|
Hong Kong |
|
22 |
-35.86%
|
Dec. 31, 2023 | USD 14.74 | 7.67% |
|
Hong Kong |
|
23 |
-68.62%
|
June 30, 2024 | USD 0.20 | 1.98% |
|
Hong Kong |
|
24 |
-288.48%
|
Dec. 31, 2023 | USD 5.81 | -1.19% |
|
Hong Kong |
|
25 |
-17,810.33%
|
Dec. 31, 2023 | USD 0.13 | -1.02% |
|
Hong Kong |
|
26 |
-19,821.41%
|
Dec. 31, 2023 | USD 0.39 | 0.30% |
|
Hong Kong |
The Health Care company in Hong Kong with the highest Net Income Margin is Pak Fah Yeow International Limited (HKSE: 0239.HK) at 40.51%.
The Health Care company in Hong Kong with the lowest Net Income Margin is Sirnaomics Ltd. (HKSE: 2257.HK) at -19,821.41%.
The top 10 Health Care companies in Hong Kong by Net Income Margin are Pak Fah Yeow International Limited, China Medical System Holdings Limited, OrbusNeich Medical Group Holdings Limited, Dawnrays Pharmaceutical (Holdings) Limited, Tycoon Group Holdings Limited, SSY Group Limited, JBM (Healthcare) Limited, The United Laboratories International Holdings Limited, Jacobson Pharma Corporation Limited and Jilin Province Huinan Changlong Bio-pharmacy Company Limited.
The bottom 10 Health Care companies in Hong Kong by Net Income Margin are Sirnaomics Ltd., SinoMab BioScience Limited, Prenetics Global Limited, HKE Holdings Limited, BeiGene, Ltd., Yunnan Energy International Co. Limited, China Resources Pharmaceutical Group Limited, Chia Tai Enterprises International Limited, Lee's Pharmaceutical Holdings Limited and Alibaba Health Information Technology Limited.